The Influence of Polytypic Structures on the Solid-state ^<13>C NMR Spectra of n-Alkanes
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-10-05
著者
-
Kawaguchi Tatsuya
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
KANEKO Fumitoshi
Department of Macromolecular Science, Graduate School of Science, Osaka University
-
Kaneko Fumitoshi
Department Of Macromolecular Science Graduate School Of Science Osaka University
-
Kawaguchi Tatsuya
Department Of Macromolecular Science Graduate School Of Science Osaka University
-
KUBOTA Hideki
Department of Macromolecular Science, Graduate School of Science, Osaka University
-
AKITA Chikayo
Department of Macromolecular Science, Graduate School of Science, Osaka University
-
Akita Chikayo
Department Of Macromolecular Science Graduate School Of Science Osaka University
関連論文
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Association of SLCO1B3 Polymorphism with Intracellular Accumulation of Imatinib in Leukocytes in Patients with Chronic Myeloid Leukemia
- TED-AJ03-370 Planar Measurement of Local Characteristics of Impinging Spray on Heating Plate
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
- Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
- Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia
- New Insights into Molecular Pathogenesis of Bone Marrow Failure in Paroxysmal Nocturnal Hemoglobinuria
- A Novel Type of Factor XI Deficiency Showing Compound Genetic Abnormalities: A Nonsense Mutation and an Impaired Transcription
- Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria
- Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia
- Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria
- T-lymphoblastic lymphoma/leukemia cells nagative for CD52 and CD59
- Migration to an inflammatory site in vivo of paroxysmal nocturnal hemoglobinuria lymphocytes
- Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
- (3-24) Application of Improved Interferometric Laser Imaging Droplet Sizing (ILIDS) System to Hollow-Cone Sprays((D-3)Diagnostics 3-Applications and Advamced Technolog)
- High-Performance Liquid Chromatographic Assay for the Determination of Nilotinib in Human Plasma
- Temperature Dependence of Structure and Dynamic Properties of Oleic Acid γand α Phases Studied by FTIR Spectroscopy
- The Influence of Polytypic Structures on the Solid-state ^C NMR Spectra of n-Alkanes
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
- Stereoselective .BETA.-C- and .BETA.-S-glycosylation of 2-deoxyribofuranose derivatives controlled by the 3-hydroxy protective group.
- Distinct Interaction of Nilotinib and Imatinib with P-Glycoprotein in Intracellular Accumulation and Cytotoxicity in CML Cell Line K562 Cells